MedPath

Influence of TMS on Attention Modulation

Not Applicable
Recruiting
Conditions
Drinking, Alcohol
Registration Number
NCT05611502
Lead Sponsor
Auburn University
Brief Summary

The purpose of this study is to help understand how attention processes influence brain engagement during emotion and social cognition. The investigators also want to know if these processes are associated with drinking alcohol.

Participation includes three study visits of about 2 hours each over approximately a month. The first visit involves a magnetic resonance imaging (MRI) scan and answering survey questions. Each of the next two visits will involve a session of transcranial magnetic stimulation (TMS, a non-invasive brain stimulation technique) followed by another MRI scan.

People in the Auburn/Opelika area 19 or older are eligible to participate. People who drink alcohol and people who do not drink or don't drink very much are invited to participate.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Age 18 or Older

2A. (Drinker Group): Reports consuming 4 [if female]/ 5 [if male] or more standard drinks on one occasion at least 2 times a month AND/OR reports consuming more than 7 [if female]/ 14 [if male] standard drinks per week on average

2B. (Healthy Volunteer Group): Reports consuming 4 [if female]/ 5 [if male] or more standard drinks on one occasion less than once a month AND reports consuming less than 7 [if female]/ 14 [if male] standard drinks per week on average

Exclusion Criteria
  1. MRI Contraindications

    1. Presence of metal in the body that would make having a 7T MRI unsafe (including facial tattoos)
    2. Claustrophobia, such that individual would be unable to stay in the MRI for up to 1 hr
    3. Hearing loss, including tinnitus, that might be made worse by MRI or TMS
  2. TMS Contraindications

    1. Has ever had a seizure, or has a family history of epilepsy
    2. Taking medications or substances that lower the seizure threshold*
    3. Implanted devices that are in the head or rely on physiological signals
    4. History of neurological disease, such as stroke or brain tumor
    5. Head injury with loss of consciousness greater than 30 minutes
    6. Actively withdrawing from alcohol
  3. Family history of schizophrenia or presence of psychotic symptoms

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in sociomoral attention switchingBaseline, immediately following TMS A, immediately following TMS B

MRI Task- analysis of behavioral data

Change in cue reactivityBaseline, immediately following TMS A, immediately following TMS B

MRI Task- analysis of behavioral data

Change in attention switchingBaseline, immediately following TMS A, immediately following TMS B

MRI Task- analysis of behavioral data

Secondary Outcome Measures
NameTimeMethod
Change in brain activity during cue reactivityBaseline, immediately following TMS A, immediately following TMS B

MRI Task- analysis of imaging (fMRI) data

Change in brain activity attention switchingBaseline, immediately following TMS A, immediately following TMS B

MRI Task- analysis of imaging (fMRI) data

Change in brain activity during sociomoral attention switchingBaseline, immediately following TMS A, immediately following TMS B

MRI Task- analysis of imaging (fMRI) data

Trial Locations

Locations (1)

Auburn University

🇺🇸

Auburn, Alabama, United States

Auburn University
🇺🇸Auburn, Alabama, United States
SCAMPI Lab
Contact
334-521-2807
scampi@auburn.edu
Samantha J Fede, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.